| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Coleman Mark is a Director at Axsome Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $7.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2019 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 16,200 | $23.10 | $374,280.00 | +1.2% | |
| May 13, 2019 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 4,650 | $21.44 | $99,696.00 | +0.7% | |
| Mar 19, 2019 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 5,100 | $12.18 | $62,118.00 | New |